infohep news

• Injecting drug use

  Does drug injection equipment other than syringes transmit hepatitis C?

  Liz Highleyman / 19 September 2017

  Sharing drug preparation paraphernalia may not significantly contribute to hepatitis C virus (HCV) transmission among people who inject drugs, according to a study recently published in The Journal of Infectious Diseases. In an experiment designed ...

• Finance, funding & health economics

  High prices of DAAs mean there's been little progress towards achieving WHO target of eliminating HCV by 2030

  Michael Carter / 13 September 2017

  Only a handful of countries are on course to achieve the World Health Organization (WHO) target of eliminating hepatitis C virus (HCV) as a major public health concern by 2030, ...

• Access to medicines & diagnostics

  The availability of direct-acting antivirals is reducing disparities in the uptake of hepatitis C treatment

  Roger Pebody / 30 August 2017

  An analysis from British Columbia, Canada shows that older people, individuals with HIV co-infection, people with cirrhosis and – to some extent – people who inject drugs have been significantly ...

• Fibrosis

  Liver fibrosis speeds up around the menopause in women with HIV and HCV co-infection

  Michael Carter / 22 August 2017

  Menopause is associated with accelerated liver fibrosis in women with HIV and hepatitis C virus (HCV) co-infection, investigators from the United States report in the online edition of Clinical Infectious Diseases. The study showed ...

• Fibrosis

  People with HIV are at risk for liver fibrosis and steatosis

  Michael Carter / 21 August 2017

  Metabolic syndrome, type 2 diabetes and obesity are risk factors for the development of liver fibrosis and steatosis (liver fat accumulation) in people living with HIV, including those who do ...